US Patent 9382289 Tubulysin compounds, methods of making and use

Patent 9382289 was granted and assigned to Bristol-Myers Squibb on July, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

93822890

Patent Inventor Names

Heng Cheng0

Qiang Cong0

Sanjeev Gangwar0

Date of Patent

July 5, 2016

Patent Application Number

146055490

Date Filed

January 26, 2015

Patent Citations Received

‌

US Patent 12077795 Method for biocatalytic protein-oligonucleotide conjugation

Patent Primary Examiner

‌

Marcela M Cordero Garcia

Patent abstract

Tubulysin compounds of the formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9382289 Tubulysin compounds, methods of making and use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API